Olympus Corporation

Tokyo Stock Exchange 7733.T

Olympus Corporation Net Cash Used For Investing Activities for the year ending March 31, 2024: USD 2.38 B

Olympus Corporation Net Cash Used For Investing Activities is USD 2.38 B for the year ending March 31, 2024, a 640.95% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.

Olympus Corporation Net Cash Used For Investing Activities for the year ending March 31, 2023 was USD -439.68 M, a 24.63% change year over year.
Olympus Corporation Net Cash Used For Investing Activities for the year ending March 31, 2022 was USD -583.40 M, a 45.67% change year over year.
Olympus Corporation Net Cash Used For Investing Activities for the year ending March 31, 2021 was USD -1.07 B, a -84.97% change year over year.
Olympus Corporation Net Cash Used For Investing Activities for the year ending March 31, 2020 was USD -580.54 M, a -6.75% change year over year.

Key data

Date	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure

Tokyo Stock Exchange: 7733.T

Olympus Corporation

CEO	Mr. Yasuo Takeuchi
IPO Date	Jan. 4, 2000
Location	Japan
Headquarters	Shinjuku Monolith
Employees	28,838
Sector	Health Care
Industries Pharmaceuticals Machinery Medical Instruments

Description

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, endoscopy system, and repair services. The Therapeutic Solutions Business segment provides urology, gynecology, ear, nose, and throat products; endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials and orthopedic equipment. The company also offers medical devices, such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and respiratory-endotherapy devices, as well as system integration and maintenance/services. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years